PMID- 30539387 OWN - NLM STAT- MEDLINE DCOM- 20191224 LR - 20191224 IS - 1559-0720 (Electronic) IS - 0163-4984 (Linking) VI - 191 IP - 1 DP - 2019 Sep TI - Abnormal Iodine Nutrition-Induced ER Stress Upregulates MCP-1 Expression Through P38/MAPK Signaling Pathway in Thyroid Cells. PG - 98-103 LID - 10.1007/s12011-018-1610-9 [doi] AB - Iodine is an important chemical for thyroid hormone synthesis. The association between iodine nutrition status and the risk of disease present U-shaped curve, as either low or high iodine nutrition status will increase the risk of thyroid diseases. Endoplasmic reticulum stress (ER stress), which can induce over expressions of inflammation factors, like monocyte chemo-attractant protein-1 (MCP-1), is related to the pathogenesis of thyroid disease. However, the correlations among iodine, MCP-1 and ER stress are not entirely clear during the pathogenesis of thyroid diseases. Present study aims to investigate how iodine nutrition status influences MCP-1 expression through P38/MAPK pathway as well as the roles of ER stress in this process. Human thyroid cells (Nthy-ori-3-1) was used as a cell model in this study. The expressions of p-P38, PERK, IRE1, ATF6, and MCP-1 were detected after the cells were treated with iodine at different concentrations with or without ER stress inhibitor (4-PBA) or P38/MAPK blocker (SB203580). The expressions of p-P38, PERK, IRE1, ATF6, and MCP-1 in Nthy-ori-3-1 cells treated with iodine at abnormal concentrations were all significantly higher than those in cells treated with iodine at normal concentration. However, addition of ER stress blocker, 4-PBA in the abnormal-iodine treated cells, decreased the expressions of p-P38, PERK, IRE1, ATF6, and MCP-1. Similarly, P38/MAPK activity inhibitor, SB203580, also decreased the expressions of p-P38 and MCP-1. Abnormal iodine nutrition status triggered ER stress and upregulated MCP-1 expression through P38/MAPK signaling pathway in thyrocyte. FAU - Chen, Xiaoshan AU - Chen X AD - The Second Clinical Medical College of Fujian Medical University, Quanzhou, 362000, Fujian, People's Republic of China. FAU - Huang, Huibin AU - Huang H AUID- ORCID: 0000-0001-6487-7029 AD - Department of Endocrinology, The Second affiliated Hospital of Fujian Medical University, NO.34 North Zhongshan Road, Quanzhou City, Fujian Province, People's Republic of China. huibinhuang@aliyun.com. FAU - Liang, Bo AU - Liang B AD - Department of Endocrinology, The Second affiliated Hospital of Fujian Medical University, NO.34 North Zhongshan Road, Quanzhou City, Fujian Province, People's Republic of China. FAU - Zhou, Jingxiong AU - Zhou J AD - Department of Endocrinology, The Second affiliated Hospital of Fujian Medical University, NO.34 North Zhongshan Road, Quanzhou City, Fujian Province, People's Republic of China. LA - eng GR - 81370886/the National Natural Science Foundation of China/ GR - 2014Y0017/Key scientific project of Fujian Province/ GR - 2018-CX-33/Innovative medical research project of Fujian Province/ PT - Journal Article DEP - 20181211 PL - United States TA - Biol Trace Elem Res JT - Biological trace element research JID - 7911509 RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) RN - 9679TC07X4 (Iodine) RN - EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases) SB - IM MH - Cell Line MH - Chemokine CCL2/*biosynthesis MH - Endoplasmic Reticulum Stress/*drug effects MH - Humans MH - Iodine/*pharmacology MH - MAP Kinase Signaling System/*drug effects MH - Thyroid Gland/cytology/*metabolism MH - Up-Regulation/*drug effects MH - p38 Mitogen-Activated Protein Kinases/metabolism OTO - NOTNLM OT - ER stress OT - Inflammatory OT - Iodine OT - MCP-1 OT - P38/MAPK OT - Thyroid cells EDAT- 2018/12/13 06:00 MHDA- 2019/12/25 06:00 CRDT- 2018/12/13 06:00 PHST- 2018/09/18 00:00 [received] PHST- 2018/12/06 00:00 [accepted] PHST- 2018/12/13 06:00 [pubmed] PHST- 2019/12/25 06:00 [medline] PHST- 2018/12/13 06:00 [entrez] AID - 10.1007/s12011-018-1610-9 [pii] AID - 10.1007/s12011-018-1610-9 [doi] PST - ppublish SO - Biol Trace Elem Res. 2019 Sep;191(1):98-103. doi: 10.1007/s12011-018-1610-9. Epub 2018 Dec 11.